While 2seventy bio Inc has overperformed by 1.34%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, TSVT fell by -23.10%, with highs and lows ranging from $6.40 to $2.78, whereas the simple moving average fell by -31.44% in the last 200 days.
On June 06, 2024, Goldman Downgraded 2seventy bio Inc (NASDAQ: TSVT) to Sell. A report published by Leerink Partners on January 31, 2024, Upgraded its rating to ‘Outperform’ for TSVT. Citigroup initiated its ‘Buy’ rating for TSVT, as published in its report on October 12, 2023. Goldman’s report from September 13, 2023 suggests a price prediction of $5 for TSVT shares, giving the stock a ‘Neutral’ rating. Guggenheim also rated the stock as ‘Neutral’.
Analysis of 2seventy bio Inc (TSVT)
Further, the quarter-over-quarter increase in sales is 12.46%, showing a positive trend in the upcoming months.
To gain a thorough understanding of 2seventy bio Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -35.38% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 4.95, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and TSVT is recording an average volume of 314.05K. On a monthly basis, the volatility of the stock is set at 7.45%, whereas on a weekly basis, it is put at 10.04%, with a loss of -5.61% over the past seven days. Furthermore, long-term investors anticipate a median target price of $6.75, showing growth from the present price of $3.03, which can serve as yet another indication of whether TSVT is worth investing in or should be passed over.
How Do You Analyze 2seventy bio Inc Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 6.31%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 87.83% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
TSVT shares are owned by institutional investors to the tune of 87.83% at present.
